Truveta is a growing collective of 30 health systems with a mission of Saving Lives with Data
Truveta Data, the most complete, timely, and clean electronic health record data, now includes more than 120 million de-identified patients
November 14, 2024 09:53 ET | Truveta
BELLEVUE, Wash., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Truveta announced today that Truveta Data, the most complete, timely, and clean electronic health record (EHR) data, now includes more than 120...
Truveta Tru enables researchers to accelerate their medical research
Truveta Studio now includes Truveta Tru, a research assistant powered by generative AI
October 29, 2024 09:18 ET | Truveta
BELLEVUE, Wash., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Today, Truveta announced its latest AI innovation – Truveta Tru, Truveta Studio’s research assistant powered by generative AI. Trained on the...
Truveta Research study published in JAMA Internal Medicine compares tirzepatide (Mounjaro) and semaglutide (Ozempic) for weight loss
Truveta’s real-world data study comparing tirzepatide (Mounjaro) and semaglutide (Ozempic) for weight loss published in JAMA Internal Medicine
July 08, 2024 11:16 ET | Truveta
BELLEVUE, Wash., July 08, 2024 (GLOBE NEWSWIRE) -- Today Truveta announced that its comparative effectiveness study exploring weight loss among patients taking semaglutide (Ozempic) and tirzepatide...
Truveta welcomes Rod Hochman, MD, president and CEO, Providence, as its new Board of Directors Chair
Truveta welcomes Rod Hochman, MD, president and CEO of Providence, as new Truveta Board of Directors Chair
May 13, 2024 09:00 ET | Truveta
BELLEVUE, Wash., May 13, 2024 (GLOBE NEWSWIRE) -- Today Truveta, a growing collective of more than 30 health systems with a mission of Saving Lives with Data, welcomes Rod Hochman, MD, president and...
Truveta is a growing collective of health systems that provide more than 18% of all daily clinical care in the US.
Truveta welcomes Patrick Caubel, Pfizer Chief Safety Officer, to its Board of Directors
December 04, 2023 09:00 ET | Truveta
BELLEVUE, Wash., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Truveta, the company with a mission of saving lives with data, welcomes its first member from the life science industry to its Board of Directors....
Truveta Language Model unlocks the depth of information within clinician notes
Truveta Language Model unlocks EHR data for the most complete and accurate medical research
April 12, 2023 09:00 ET | Truveta
BELLEVUE, Wash., April 12, 2023 (GLOBE NEWSWIRE) -- Today Truveta introduces the Truveta Language Model (TLM), a large-language, multi-modal AI model for transforming electronic health record (EHR)...
Breakthrough COVID-19 infections by comorbidity
Truveta’s COVID-19 breakthrough infections research published in Vaccine
February 23, 2023 09:00 ET | Truveta
BELLEVUE, Wash., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new COVID-19 research published in Vaccine using de-identified patient data from Truveta Studio™. The new research...
Breakthrough COVID-19 infections by comorbidity
Truveta’s COVID-19 breakthrough infections research published in Vaccine
February 23, 2023 09:00 ET | Truveta
BELLEVUE, Wash., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new COVID-19 research published in Vaccine using de-identified patient data from Truveta Studio™. The new research...
RSV: All age groups by season
Truveta Research shares new insights on RSV hospitalization trends
January 19, 2023 12:00 ET | Truveta
BELLEVUE, Wash., Jan. 19, 2023 (GLOBE NEWSWIRE) -- Today, Truveta released new research comparing the rates of RSV to previous years. With the rising rates of respiratory syncytial virus (RSV)...
COVID-19 disparities in access to treatment
Truveta’s COVID-19 health equity research published in Frontiers in Public Health
January 19, 2023 09:00 ET | Truveta
BELLEVUE, Wash., Jan. 19, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new COVID-19 health equity research published in Frontiers in Public Health using de-identified patient data from Truveta...
Next Page keyboard_arrow_right